CCL2 and head and neck squamous cell carcinoma: Paracrine CCL2 further drove glutathione accumulation and cisplatin resistance in HNSCC by upregulating solute carrier family 1 member 5 (SLC1A5) and solute carrier family 7 member 11 (SLC7A11).